WallStreetZenWallStreetZen

NASDAQ: ATRA
Atara Biotherapeutics Inc Stock Ownership - Who owns Atara Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atara Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ecor1 Capital LLC10% Owner2026-05-07507,407$9.35
$4.74MBuy
Panacea Innovation Ltd10% Owner2026-05-07313,446$10.10
$3.17MSell
Panacea Innovation Ltd10% Owner2026-03-175$5.23
$26.15Sell
Anhco NguyenPresident and CEO2026-03-021,442$5.09
$7.34kSell
Anhco NguyenPresident and CEO2026-03-0258$5.08
$294.64Sell
Yanina GranthuertaChief Accounting Officer2026-03-0224$5.08
$121.85Sell
Yanina GranthuertaChief Accounting Officer2026-03-021,603$5.08
$8.14kSell
Yanina GranthuertaChief Accounting Officer2026-03-02377$5.08
$1.92kSell
Yanina GranthuertaChief Accounting Officer2026-03-02100$5.08
$508.30Sell
Anhco NguyenPresident and CEO2026-03-02198$5.08
$1.01kSell

1 of 3

ATRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATRA insiders and whales buy or sell their stock.

ATRA Shareholders

What type of owners hold Atara Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Panacea Innovation Ltd29.41%2,649,559$24.24MInsider
Domain Partners VIII LP23.77%2,141,542$19.60MInsider
Adiumentum Capital Fund I LP13.42%1,209,395$11.07MInsider
Ecor1 Capital LLC11.59%1,044,593$9.56MInsider
Joel S. Marcus9.99%899,855$8.23MInsider
Adage Capital Partners GP LLC7.77%700,000$6.41MInstitution
Isaac E. Ciechanover6.91%622,930$5.70MInsider
Eric Dobmeier6.25%563,325$5.15MInsider
Redmile Group LLC4.90%441,701$4.04MInstitution
Redmile Group LLC4.90%441,701$4.04MInsider

1 of 3

ATRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATRA16.92%83.08%Net BuyingNet Buying
RNTX13.32%42.45%Net BuyingNet Buying
FBIO16.09%48.60%Net BuyingNet Buying
TELO3.26%23.07%Net BuyingNet Buying
CSBR1.94%98.06%Net Buying
View Top Biotech Stocks

Atara Biotherapeutics Stock Ownership FAQ

Who owns Atara Biotherapeutics?

Atara Biotherapeutics (NASDAQ: ATRA) is owned by 28.46% institutional shareholders, 139.71% Atara Biotherapeutics insiders, and 0.00% retail investors. Panacea Innovation Ltd is the largest individual Atara Biotherapeutics shareholder, owning 2.65M shares representing 29.41% of the company. Panacea Innovation Ltd's Atara Biotherapeutics shares are currently valued at $24.93M.

If you're new to stock investing, here's how to buy Atara Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.